Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news
With Innovation, We Can Keep Reducing the Toll of COVID-19
Scrolling through social media these days, you’ll see that loud extremists continue to dominate COVID-19 discourse. At one pole are the denialists who argue—incorrectly—that COVID is “just a cold.” At the other are those who suggest that no meaningful progress has been made in controlling its devastation. The truth, of course, is somewhere in the middle.
We have not yet extricated ourselves from the peril of SARS-CoV-2, and wishing COVID-19 gone does not make it so. Surging case numbers provide opportunities to produce the next variant as the virus evolves to escape antibodies accumulated from...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Edward Nirenberg, Gavin Yamey and Ilan Schwartz Tags: Uncategorized COVID-19 freelance Source Type: news
This Is the Phase of the Pandemic Where Life Returns To Normal
At the supermarket, work, schools, restaurants, sports events, and airports we are witnessing a remarkable change. Masks are rarely seen. People are hugging, crowding, traveling. The latest Google COVID Community Mobility Report shows that most forms of activity have returned to near normal relative to the pre-pandemic baseline. But some people are understandably confused and conflicted. Mainstream media and many “experts“ continue to admonish us to avoid exposure. Are we indeed still in the treacherous pandemic phase? Are the throngs being irresponsible? Or are we witnessing a crowd-sourced, rational resetting...
Source: TIME: Health - August 3, 2022 Category: Consumer Health News Authors: Steven Phillips Tags: Uncategorized Source Type: news
GSK signs agreement to support pandemic preparedness in Europe
GSK plc (LSE/NYSE: GSK) announced it had signed a framework contract with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA) for the reservation of future production and supply of 85 million doses of its pandemic influenza vaccine Adjupanrix [pandemic influenza vaccine (split virion, inactivated, adjuvanted)]. (Source: World Pharma News)
Source: World Pharma News - August 1, 2022 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
Flu Vaccine Tied to Lower Alzheimer Disease Risk in Older Adults
TUESDAY, July 26, 2022 -- Influenza vaccination is associated with a reduced Alzheimer disease (AD) risk among older U.S. adults, according to a study published online June 13 in the Journal of Alzheimer ' s Disease.
Avram S. Bukhbinder, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2022 Category: Pharmaceuticals Source Type: news
